ANZSN/APCN 2016 Perth Australia

ANZSN/APCN 2016

The 15th Asian Pacific Congress of Nephrology & 52nd Australian and New Zealand Society of Nephrology Annual Scientific Meeting was held at the Perth Concention and Exhibition Centre, Western Australia, on 17-21 September 2016.

Photos and presentations (as video) are available below.

« 1 of 2 »

Presentations

Click on the title to view video of presentation.

Sep 18 – Seminar 1 Aetiology Pathogenesis
Prof Jonathan Hodgson – Vascular Health Benefits of Vasoactive Components of Plant Foods
A/Prof. Reiko Inagi – Renal Cellular Metabolism and Oxidative Stress
Prof. Hyug Moo Kwon – Association of the TonEBP Gene and Metabolic Diseases

Sep 18 – Seminar 2 – Transplantation
Prof. Kazunari Tanabe – ABO-Incompatible Kidney Transplantation – The Japanese Experience and Long-Term Outcomes
Prof. Philip O’Connell – Molecular Diagnostics, Biomarkers and Immune Monitoring in Transplantation

Sep 18 – KDIGO Hypertension Guideline Symposium
Dr Allan Collins – Reducing Global Burden of CKD and CVD: Devising Effective Public Health Messages and Policies for Blood Pressure Management
Prof. Vlado Perkovic – New Data for an Old Treatment – BP Lowering in 2016
Hypertension Q&A

Sep 18 – KHACARI Symposium on ADPKD Guidelines
Dr. Vincent Lee – Management of ICAs in ADPKD
Dr. Andrew Mallett – Pharmacological Management of ADPKD

Sep 18 – Seminar 3 – Challenges In Managing CKD AKI
Prof. Tazeen Jafar – Overcoming Health Systems Challenges in Managing CKD in the Community

Sep 18 – APSN Young Investigator – Basic
Dr Yosuke Hirakawa – Determination of urinary oxygen tension by phosphorescence lifetime measurement
Mr. Brijesh Yadav – IS HIGHER TH17 FREQUENCY CAUSES CHRONIC CALCINEURIN INHIBITOR TOXICITY IN RENAL ALLOGRAFT RECIPIENTS?
Miss Wenjuan Wang – HYDROGEN SULFIDE MEDIATES THE PROTECTION OF DIETARY RESTRICTION AGAINST RENAL SENESCENCE IN AGED F344 RATS

Sep 18 – Seminar 4 – Dialysis
Prof. Mai-Szu Wu – Initiation of Dialysis and Choice of Dialysis Modality
Prof. Robert Walker – Dialysis Outcomes in the Elderly, What is Important?
Dr. Katherine Bristowe – End of Life Planning in Dialysis

Sep 18 – Seminar 5 – CKD AKI
Dr. Kunitoshi Iseki – Haematuria Should be Included as a CKD Risk Factor

Sep 19 – CME Nephrology Update
Dr. Giovanni Strippoli – Challenges in Improving CV Outcomes in ESKD

Sep 19 – Seminar 6 – Transplantation
Dr. Jeremy Chapman – Global Initiatives in Biovigilance and Surveillance: Preventing Disease and Emerging Risks in Transplantation
Daniel Chan – Update on Hepatitis B Infection and Kidney Transplantation
Prof. Sang-Oh Lee – Living Donor and Recipient Screening for Latent Tuberculosis Infection

Sep 19 – Seminar 7 – CKD AKI
A/Prof. Kamal Sud – Managing AKI Survivors to Reduce Future CKD Burden

Sep 19 – Plenary
Prof. Ravi Thadhani – Pre-eclampsia: From Science to Medicine

Sep 19 – KDIGO CKD MBD Symposium
Dr Markus Ketteler – New Guidelines on CKD-MBD – Update on Calcium, Phosphorus and sHPT
A/Prof. Nigel Toussaint – New Guidelines on CKDMBD – Update on Bone Quality and Vitamin D
Dr Hirotaka Komaba – Medical and Surgical Management of Secondary Hyperparathyroidism: What can we Learn from Regional Variation?

Sep 19 – Seminar 8 – Dialysis
Prof. Philip Li – The Role of Bioimpedence Spectroscopy in Fluid Management of PD Patients
Prof. Adrian Liew – Glucose Sparing Strategies: Is the Evidence Strong Enough to Justify the Cost?
Dr. David Johnson – Management of PD Peritonitis: What Evidence do we Need?

Sep 19 – APSN Young Investigator Award
Dr. Ashok Yadav – CHOLECALCIFEROL SUPPLEMENTATION AND VASCULAR FUNCTION IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
MD, PhD Akihiro Tsuda – GLOMERULAR HYPERFILTRATION AND INCREASED EFFERENT ARTERIOLAR RESISTANCE ARE PRESENT IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE
Dr. Yuta Matsukuma – GERIATRIC NUTRITIONAL RISK INDEX IS STRONGLY ASSOCIATED WITH INFECTION-RELATED MORTALITY IN HEMODIALYSIS PATIENTS: THE Q-COHORT STUDY
Dr Pahnwat T. Taweesedt – Pulmonary Hypertension in Hospitalized End-Stage-Renal Disease Patients

Sep 19 – Seminar 9 – Aetiology Pathogenesis
A/Prof. Chrishan Samuel – Mediators of Fibrosis in Chronic Kidney Disease
Prof. Sydney Tang – Toll-Like Receptor in Diabetic Nephropathy

Sep 19 – AKTN Session
Lai Seong Hooi – Australia – Malaysia Collaboration and FAVOURED Study
Dr. Matthew Roberts – BLOCADE Trial Results
Dr. Allison Tong – Composing a New Song for Nephrology
Prof. Vlado Perkovic – Opportunities in Pragmatic Trials

Sep 20 – CME Nephrology Update
Prof. Ravi Thadhani – Pregnancy and Kidney Disease: A Review

Sep 20 – Seminar 10 – CKD AKI
Dr. Giovanni Strippoli – Efficacy and Safety of Blood Pressure-Lowering Agents in Adults with Diabetes and CKD
Prof. Ravi Thadhani – Vitamin D: The More we Know, the Less we Know
Prof. Markus Schlaich – The Role of the Sympathetic Nervous System in Blood Pressure Regulation in CKD

Sep 20 – Seminar 11 – Transplantation
Ms Jenny Koo – Development of Organ Donation Initiatives in Hong Kong
Prof. Po-Chang Lee – Promoting Organ Donation in Taiwan – Difficulties and Innovations

Sep 20 – Hyperkalaemia
Prof. Masaomi Nangaku – Epidemiology of Hyperkalemia: Who is at Risk?
Prof. Vlado Perkovic – The Clinical Impact of Hyperkalemia
Q&A Session

Sep 20 – New Considerations in Delivering Home Haemodialysis
Dr Mike Copland – Home Haemodialysis Therapy Comparisons between Conventional Delivery Systems and NxStage
Dr. Shyam Dheda – The Use of NxStage to Facilitate Home Haemodialysis in Far North Queensland

Sep 20 – Plenary
Dr. Peter Doherty – The Killer Defence

Sep 20 – Seminar 12 – Haemodialysis
Dr. Colin Hutchison – High Cut-Off Dialysis for End Stage Renal Disease

Sep 20 – ANZDATA
Dr. Samuel Chan – Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients
Dr. Philip Clayton – Research Developments in the Registry

Sep 20 – Seminar 13 – CKDAKI
A/Prof. Karen Moritz – Maternal Influence on Adult Outcomes
Prof. Masaomi Nangaku – Epigenetics of Renal Disease

Sep 20 – APSN Registries
Professor Dong-Chan Jin – Lessons from 30 Years’ Data, Korean ESRD Registry: 1985-2015
Prof. Chih-Cheng Hsu – CKD Prevention in Taiwan: Achievements and Challenges

Sep 21 – Seminar 14 – Transplantation
Prof. Sharon Ricardo – The Future of Stem Cells in Transplantation
Dr. Natasha Rogers – The Spectrum of Dendritic Cells and the Promise of Immunotherapy in Transplantation
Dr. Karen Dwyer – Ischaemia Reperfusion Injury in Kidney Allografts – Mechanisms and Opportunity for Intervention

Sep 21 – Seminar 15 – Dialysis
Prof. Sang Kyung Jo – CRRT in Critically Ill AKI Patients
Prof. Kent Doi – Indication of Renal Replacement Therapy for AKI
Prof. Ranistha Ratanarat – Prolonged Intermittent Renal Replacement Therapy in AKI

Sep 21 – Closing Plenary
Dr. Katherine Bristowe – Supporting the Needs of People with End Stage Kidney Disease: Lessons from Recent Research

Closing Ceremony